vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and RBC Bearings INC (RBC). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $461.6M, roughly 1.1× RBC Bearings INC). RBC Bearings INC runs the higher net margin — 14.6% vs 6.8%, a 7.8% gap on every dollar of revenue. On growth, RBC Bearings INC posted the faster year-over-year revenue change (17.0% vs -1.7%). Over the past eight quarters, RBC Bearings INC's revenue compounded faster (5.6% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
Dover Corporation is an American conglomerate manufacturer of industrial products. The Downers Grove, Illinois-based company was founded in 1955. As of 2021, Dover's business was divided into five segments: Engineered Products, Clean Energy and Fueling, Imaging & Identification, Pumps & Process Solutions and Climate and Sustainability Technologies. Dover is a constituent of the S&P 500 index and trades on the New York Stock Exchange under the symbol DOV. Dover was ranked 448 in the 2024 Fortu...
MD vs RBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $461.6M |
| Net Profit | $33.7M | $67.4M |
| Gross Margin | — | 44.3% |
| Operating Margin | 9.9% | 22.3% |
| Net Margin | 6.8% | 14.6% |
| Revenue YoY | -1.7% | 17.0% |
| Net Profit YoY | 10.5% | 16.4% |
| EPS (diluted) | $0.40 | $2.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $461.6M | ||
| Q3 25 | $492.9M | $455.3M | ||
| Q2 25 | $468.8M | $436.0M | ||
| Q1 25 | $458.4M | $437.7M | ||
| Q4 24 | $502.4M | $394.4M | ||
| Q3 24 | $511.2M | $397.9M | ||
| Q2 24 | $504.3M | $406.3M | ||
| Q1 24 | $495.1M | $413.7M |
| Q4 25 | $33.7M | $67.4M | ||
| Q3 25 | $71.7M | $60.0M | ||
| Q2 25 | $39.3M | $68.5M | ||
| Q1 25 | $20.7M | $72.7M | ||
| Q4 24 | $30.5M | $57.9M | ||
| Q3 24 | $19.4M | $54.2M | ||
| Q2 24 | $-153.0M | $61.4M | ||
| Q1 24 | $4.0M | — |
| Q4 25 | — | 44.3% | ||
| Q3 25 | — | 44.1% | ||
| Q2 25 | — | 44.8% | ||
| Q1 25 | — | 44.2% | ||
| Q4 24 | — | 44.3% | ||
| Q3 24 | — | 43.7% | ||
| Q2 24 | — | 45.3% | ||
| Q1 24 | — | 43.1% |
| Q4 25 | 9.9% | 22.3% | ||
| Q3 25 | 13.8% | 21.5% | ||
| Q2 25 | 12.8% | 23.2% | ||
| Q1 25 | 7.0% | 23.0% | ||
| Q4 24 | 7.8% | 21.7% | ||
| Q3 24 | 6.6% | 21.6% | ||
| Q2 24 | -31.3% | 24.0% | ||
| Q1 24 | 3.2% | 22.8% |
| Q4 25 | 6.8% | 14.6% | ||
| Q3 25 | 14.5% | 13.2% | ||
| Q2 25 | 8.4% | 15.7% | ||
| Q1 25 | 4.5% | 16.6% | ||
| Q4 24 | 6.1% | 14.7% | ||
| Q3 24 | 3.8% | 13.6% | ||
| Q2 24 | -30.3% | 15.1% | ||
| Q1 24 | 0.8% | — |
| Q4 25 | $0.40 | $2.13 | ||
| Q3 25 | $0.84 | $1.90 | ||
| Q2 25 | $0.46 | $2.17 | ||
| Q1 25 | $0.24 | $2.33 | ||
| Q4 24 | $0.37 | $1.82 | ||
| Q3 24 | $0.23 | $1.65 | ||
| Q2 24 | $-1.84 | $1.90 | ||
| Q1 24 | $0.05 | $1.92 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $107.6M |
| Total DebtLower is stronger | $570.5M | $990.2M |
| Stockholders' EquityBook value | $865.9M | $3.3B |
| Total Assets | $2.2B | $5.1B |
| Debt / EquityLower = less leverage | 0.66× | 0.30× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $107.6M | ||
| Q3 25 | $340.1M | $91.2M | ||
| Q2 25 | $224.7M | $132.9M | ||
| Q1 25 | $99.0M | $36.8M | ||
| Q4 24 | $229.9M | — | ||
| Q3 24 | $103.8M | — | ||
| Q2 24 | $19.4M | $76.8M | ||
| Q1 24 | $8.0M | $63.5M |
| Q4 25 | $570.5M | $990.2M | ||
| Q3 25 | $577.2M | $1.1B | ||
| Q2 25 | $583.9M | $915.6M | ||
| Q1 25 | $590.5M | $920.1M | ||
| Q4 24 | $597.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $1.2B |
| Q4 25 | $865.9M | $3.3B | ||
| Q3 25 | $890.7M | $3.2B | ||
| Q2 25 | $833.8M | $3.1B | ||
| Q1 25 | $789.2M | $3.0B | ||
| Q4 24 | $764.9M | $2.9B | ||
| Q3 24 | $732.5M | $2.9B | ||
| Q2 24 | $706.5M | $2.8B | ||
| Q1 24 | $856.2M | $2.8B |
| Q4 25 | $2.2B | $5.1B | ||
| Q3 25 | $2.2B | $5.1B | ||
| Q2 25 | $2.1B | $4.8B | ||
| Q1 25 | $2.0B | $4.7B | ||
| Q4 24 | $2.2B | $4.7B | ||
| Q3 24 | $2.1B | $4.7B | ||
| Q2 24 | $2.0B | $4.7B | ||
| Q1 24 | $2.2B | $4.7B |
| Q4 25 | 0.66× | 0.30× | ||
| Q3 25 | 0.65× | 0.34× | ||
| Q2 25 | 0.70× | 0.29× | ||
| Q1 25 | 0.75× | 0.30× | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.43× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $122.1M |
| Free Cash FlowOCF − Capex | — | $99.1M |
| FCF MarginFCF / Revenue | — | 21.5% |
| Capex IntensityCapex / Revenue | — | 5.0% |
| Cash ConversionOCF / Net Profit | 3.39× | 1.81× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $122.1M | ||
| Q3 25 | $137.3M | $88.4M | ||
| Q2 25 | $137.2M | $120.0M | ||
| Q1 25 | $-117.5M | — | ||
| Q4 24 | $133.0M | $84.0M | ||
| Q3 24 | $91.8M | — | ||
| Q2 24 | $107.0M | $97.4M | ||
| Q1 24 | $-125.2M | — |
| Q4 25 | — | $99.1M | ||
| Q3 25 | — | $71.7M | ||
| Q2 25 | — | $104.3M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $73.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $88.4M | ||
| Q1 24 | — | — |
| Q4 25 | — | 21.5% | ||
| Q3 25 | — | 15.7% | ||
| Q2 25 | — | 23.9% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 18.7% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 21.8% | ||
| Q1 24 | — | — |
| Q4 25 | — | 5.0% | ||
| Q3 25 | — | 3.7% | ||
| Q2 25 | — | 3.6% | ||
| Q1 25 | — | 3.2% | ||
| Q4 24 | — | 2.6% | ||
| Q3 24 | — | 4.1% | ||
| Q2 24 | — | 2.2% | ||
| Q1 24 | — | — |
| Q4 25 | 3.39× | 1.81× | ||
| Q3 25 | 1.91× | 1.47× | ||
| Q2 25 | 3.49× | 1.75× | ||
| Q1 25 | -5.66× | — | ||
| Q4 24 | 4.36× | 1.45× | ||
| Q3 24 | 4.72× | — | ||
| Q2 24 | — | 1.59× | ||
| Q1 24 | -31.03× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
RBC
| Domestic | $413.3M | 90% |
| Foreign | $48.3M | 10% |
